Cargando…
Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
Inflammation is a complicated disorder that is produced as a result of consecutive processes. 5-LOX (5-lipoxygenase) is accountable for various inflammation mediators and leukotrienes synthesis, and its inhibition is the target of anti-inflammation therapeutics. Fungi have acquired enormous attentiv...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782297/ https://www.ncbi.nlm.nih.gov/pubmed/36556460 http://dx.doi.org/10.3390/life12122095 |
_version_ | 1784857308692480000 |
---|---|
author | Khayat, Maan T. Mohammad, Khadijah A. Mohamed, Gamal A. Safo, Martin K. Ibrahim, Sabrin R. M. |
author_facet | Khayat, Maan T. Mohammad, Khadijah A. Mohamed, Gamal A. Safo, Martin K. Ibrahim, Sabrin R. M. |
author_sort | Khayat, Maan T. |
collection | PubMed |
description | Inflammation is a complicated disorder that is produced as a result of consecutive processes. 5-LOX (5-lipoxygenase) is accountable for various inflammation mediators and leukotrienes synthesis, and its inhibition is the target of anti-inflammation therapeutics. Fungi have acquired enormous attentiveness because of their capability to biosynthesize novel bio-metabolites that reveal diversified bio-activities. A new tetracyclic triterpenoid, integracide L (1), along with integracides B (2) and F (3), were separated from Mentha longifolia-associated Fusarium sp. (FS No. MAR2014). Their structures were verified utilizing varied spectral analyses. The isolated metabolites (1–3), alongside the earlier reported integracides G (4), H (5), and J (6), were inspected for 5-LOX inhibition capacity. Interestingly, 1–6 possessed marked 5-LOX inhibition potentials with IC(50)s ranging from 1.18 to 3.97 μM compared to zileuton (IC(50) 1.17 µM). Additionally, molecular docking was executed to examine the interaction among these metabolites and 5-LOX, as well as to validate the in vitro findings. The docking study revealed their inhibitory activity interactions in the binding pocket. These findings highlighted the potential of integracides as lead metabolites for anti-inflammation drug discovery. |
format | Online Article Text |
id | pubmed-9782297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97822972022-12-24 Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies Khayat, Maan T. Mohammad, Khadijah A. Mohamed, Gamal A. Safo, Martin K. Ibrahim, Sabrin R. M. Life (Basel) Article Inflammation is a complicated disorder that is produced as a result of consecutive processes. 5-LOX (5-lipoxygenase) is accountable for various inflammation mediators and leukotrienes synthesis, and its inhibition is the target of anti-inflammation therapeutics. Fungi have acquired enormous attentiveness because of their capability to biosynthesize novel bio-metabolites that reveal diversified bio-activities. A new tetracyclic triterpenoid, integracide L (1), along with integracides B (2) and F (3), were separated from Mentha longifolia-associated Fusarium sp. (FS No. MAR2014). Their structures were verified utilizing varied spectral analyses. The isolated metabolites (1–3), alongside the earlier reported integracides G (4), H (5), and J (6), were inspected for 5-LOX inhibition capacity. Interestingly, 1–6 possessed marked 5-LOX inhibition potentials with IC(50)s ranging from 1.18 to 3.97 μM compared to zileuton (IC(50) 1.17 µM). Additionally, molecular docking was executed to examine the interaction among these metabolites and 5-LOX, as well as to validate the in vitro findings. The docking study revealed their inhibitory activity interactions in the binding pocket. These findings highlighted the potential of integracides as lead metabolites for anti-inflammation drug discovery. MDPI 2022-12-13 /pmc/articles/PMC9782297/ /pubmed/36556460 http://dx.doi.org/10.3390/life12122095 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Khayat, Maan T. Mohammad, Khadijah A. Mohamed, Gamal A. Safo, Martin K. Ibrahim, Sabrin R. M. Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies |
title | Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies |
title_full | Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies |
title_fullStr | Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies |
title_full_unstemmed | Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies |
title_short | Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies |
title_sort | integracides: tetracyclic triterpenoids from fusarium sp.—their 5-lipoxygenase inhibitory potential and structure–activity relation using in vitro and molecular docking studies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782297/ https://www.ncbi.nlm.nih.gov/pubmed/36556460 http://dx.doi.org/10.3390/life12122095 |
work_keys_str_mv | AT khayatmaant integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies AT mohammadkhadijaha integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies AT mohamedgamala integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies AT safomartink integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies AT ibrahimsabrinrm integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies |